Inhibitory effects of clonidine and dopamine on adenylate cyclase of rabbit ciliary processes

References

• Waltzmann M. B. Woods W. D. Some characteristics of an adenyl cyclase preparation from rabbit ciliary processes tissue. Exp. Eye Res. 1971; 12: 99–111
   PubMed Web of Science ®Google Scholar
• Čepelik J., Černohorský M. The effects of adrenergic agonists and antagonists on the adenylate cyclase in albino rabbit ciliary processes. Exp. Eye Res. 1981; 32: 291–299
   PubMed Web of Science ®Google Scholar
• Gregory D. S., Bausher L. P., Brom-berg B. B, Sears M. L. The beta-adrenergic receptor and adenyl cyclase of rabbit ciliary processes. New Directions in Ophthalmic Research, M. L. Sears. Yale University Press, New Haven, CT, USA 1981; 127–145
   Google Scholar
• Mittag T. W. Tormay A. Adrenergic receptor subtypes in rabbit iris-ciliary body membranes: classification by radioligand studies. Exp. Eye Res. 1985; 40: 239–249
   PubMed Web of Science ®Google Scholar
• Mittag T. W., Tormay A., Severin C., Podos S. M. Alpha-adrener-gic antagonists: Correlation of the effect on intraocular pressure and on α2-adrenergic receptor binding speciflcity in the rabbit eye. Exp. Eye Res. 1985; 40: 591–599
   PubMed Web of Science ®Google Scholar
• Mittag T. W. Tormay A. Drug responses of adenylate cyclase in iris-ciliary body determined by adenine labelling. Invest. Ophthal-mol. Vis. Sci. 1985; 26: 396–399
   PubMed Web of Science ®Google Scholar
• Bausher L. P., Gregory D. S. Sears M. L. Interaction between alpha- and beta-adrenergic receptors in rabbit ciliary processes. Curr. Eye Res. 1987; 6: 497–505
   PubMed Web of Science ®Google Scholar
• Bausher L. P., Gregory D. S. Sears M. L. Alpha-2-adrenergic and VIP receptors in rabbit ciliary processes interact. Curr. Eye Res. 1989; 8: 47–54
   PubMed Web of Science ®Google Scholar
• Kintz P., Hlmber J., de Burlet G., Andermann G. Characterization of alpha-adrenergic receptors, negatively coupled to adenylate cyclase, in rabbit ciliary processes. Curr. Eye Res. 1988; 7: 287–292
   PubMed Web of Science ®Google Scholar
• Ramachandran J. A new simple method for separation of adenosine 3,5-cyclic monophosphate from other nucleotides and its use in the assay of adenyl cyclase. Analyt. Biochem 1971; 43: 227–239
   PubMed Web of Science ®Google Scholar
• Hynie S., Wenke M. The absence of stimulation of lipolysis by papaverlne, a strong inhibitor of phosphodiesterase. Eur. J. Pharmacol. 1975; 30: 230–240
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosenbrough N. J., Farr A. L. Randall R. J. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• van Rossum J. M. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch. Int. Pharmacodyn 1963; 143: 299–330
   PubMedGoogle Scholar
• Symons R. H. The rapid, simple and improved preparation of high specific activity α-[32P]dATP and α-[32P]ATP. Nucleic Acids Res. 1977; 4: 4347–4355
   PubMed Web of Science ®Google Scholar
• Levltzki A. Regulation of hormone-sensitive adenylate cyclase. Trends Pharmacol. Sci. 1987; 8: 299–303
   Web of Science ®Google Scholar
• Insel P. A., Stengel D., Ferry N., Hanoune J. Regulation of adenylate cyclase of human platelet membranes by forskolin. J. Biol. Chem. 1982; 257: 7458–7490
   Web of Science ®Google Scholar
• Kitamura Y., Nomura Y., Segawa T. Possible involvement of inhibitory GTP binding regulatory protein in α2-adrenoceptor-mediated inhibition of adenylate cyclase activity in cerebral cortical membranes of rats. J. Neurochem. 1985; 45: 1504–1508
   PubMed Web of Science ®Google Scholar
• Sabol S. I. Nirenberg M. Regulation of adenylate cyclase of neuroblastoma x glioma hybrid cells by α-adrenergic receptors. J. Biol. Chem. 1979; 254: 1913–1920
   PubMed Web of Science ®Google Scholar
• Yamazaki S., Katada T., Ui M. Alpha2-adrenergic inhibition of insulin secretion via interference with cyclic AMP generation in rat pancreatic islets. Mol. Pharmacol. 1982; 21: 648–653
   PubMed Web of Science ®Google Scholar
• Kahn D. J., Mitrius J. C., U'Pri-chard D. C. Alpha2-adrenergic receptors in neuroblastoma x glioma hybrid cells. Characterization with agonist and antagonist radioligands and relationship to adenylate cyclase. Mol. Pharmacol. 1982; 21: 17–26
   PubMed Web of Science ®Google Scholar
• Woodcock E., Johnston C., Olson C. Alpha-adrenergic inhibition of renal cortical adenylate cyclase. J. Cyclic Nucleotide Res. 1980; 6: 261–269
   PubMedGoogle Scholar
• Fain J. N., Pointer R. H. Ward W. F. Effects of adenosine nucleosides on adenylate cyclase, phosphodiesterase, cAMP accumulation and lipolysis in fat cells. J. Biol. Chem. 1972; 247: 6866–6872
   PubMed Web of Science ®Google Scholar
• Garcia-Morales P., Dufrane S. P., Sener A., Valverde I., Malaisse W. J. Inhibitory effect of clo-nidine upon adenylate cyclase activity, cAMP production, and insulin release in rat pancreatic islets. Biosci. Reports 1984; 4: 511–521
   PubMed Web of Science ®Google Scholar
• Jakobs K. H., Minuth M., Aktories K. Sodium regulation of hormone-sensitive adenylate cyclase. J. Receptor Res. 1984; 4: 443–458
   PubMed Web of Science ®Google Scholar
• Jakobs K. H., Aktories K., Minuth M., Schultz G. Inhibition of adenylate cyclase. Adv. Cyclic Nucleotide and Protein Phosphoryl. Res. 1985; 19: 137–150
   PubMedGoogle Scholar
• Mittag W. T., Tormay A., Podos S. M. Manganous chloride stimulation of adenylate cyclase responsiveness in ocular ciliary process membranes. Exp. Eye Res. 1988; 46: 841–851
   PubMed Web of Science ®Google Scholar
• Mattera R., Toro M. J., Codina J., Blrnbaumer L. Inhibition of adenylyl cyclase by hormones: Structural and functional correlates. Mechanisms of Signal Transduction by Hormones and Growth Factors. Alan R. Liss, Inc., New YorkUSA 1987; 43–64
   Google Scholar
• Mittag T. W., Tormay A., Podos S. M. Vasoactive intestinal po-lypeptide and intraocular pressure: Adenylate cyclase activation and binding sites for VIP in membranes of ocular ciliary processes. J. Pharmacol. Exp. Ther. 1987; 241: 230–235
   PubMed Web of Science ®Google Scholar
• Gilman A. G. Guanine nucleoti-de-binding regulatory proteins and transmembrane signaling. Fidia Research Foundation Neuroscience Award Lectures, A. G. Gilman, et al. Raven Press, New YorkUSA 1988; Vol. 2: 11–31
   Google Scholar
• Jenner P., Marsden C D. Substituted benzamlde drugs as selective neuroleptic agents. Neuropharmacology 1981; 20: 1285–1293
   PubMed Web of Science ®Google Scholar